METHOD FOR MEASURING GLYCOSYLATED HEMOGLOBIN, AND DEVICE FOR MEASURING GLYCOSYLATED HEMOGLOBIN

The purpose of the present invention is to eliminate the effect of abnormal hemoglobin when a blood sample containing abnormal hemoglobin D, abnormal hemoglobin S, or abnormal hemoglobin C is measuredby cation exchange chromatography, and to obtain an sA1c measurement result reflecting a symptom of...

Full description

Saved in:
Bibliographic Details
Main Author HASEGAWA SACHIYUKI
Format Patent
LanguageChinese
English
Published 21.12.2018
Subjects
Online AccessGet full text

Cover

More Information
Summary:The purpose of the present invention is to eliminate the effect of abnormal hemoglobin when a blood sample containing abnormal hemoglobin D, abnormal hemoglobin S, or abnormal hemoglobin C is measuredby cation exchange chromatography, and to obtain an sA1c measurement result reflecting a symptom of the test subject providing the blood sample. The abovementioned problem is solved by a method for measuring the ratio (%) of sA1c, characterized by comprising calculating the area of the peak when a peak originating from abnormal hemoglobin D, abnormal hemoglobin S, or abnormal hemoglobin C is identified and measuring the ratio (%) of sA1c corrected using the calculation result. 本发明的目的在于,在利用阳离子交换色谱测定含有异常血红蛋白D、异常血红蛋白S或异常血红蛋白C的血液样本的情况下,排除该异常血红蛋白带来的影响,得到反映提供血液样本的受试者的症状的SA1c测定结果。本发明通过SA1c的比例(%)的测定方法来解决上述课题,该方法的特征在于,在鉴定来自异常血红蛋白D、异常血红蛋白S或异常血红蛋白C的峰的情况下,计算出该峰的面积,使用该计算结果测定校正后的SA1c的比例(%)。
Bibliography:Application Number: CN201780025012